NYSCF CEO Susan L. Solomon Featured at ARM Biotech Showcase
During the 2013 Biotech Showcase in San Francisco, NYSCF CEO Susan L. Solomon presented on NYSCF’s role in the future of stem cell research at the Alliance for Regenerative Medicine’s State of the Industry Briefing. An audience of biotech and pharmaceutical colleagues learned about NYSCF’s singular ability to produce thousands of induced pluripotent stem cell lines on an automated, proprietary technology platform. This NYSCF Global Stem Cell Array provides the entire stem cell community with an invaluable resource for consistent stem cell lines for disease modeling and drug discovery. This meeting was held concurrently to the JP Morgan Healthcare Conference.